Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lhx2-/- mice develop liver fibrosis.

Ewa Wandzioch1, Asa Kolterud, Maria Jacobsson

  • 1Umeå Center for Molecular Medicine, Umeå University, 901 87 Umeå, Sweden.

Proceedings of the National Academy of Sciences of the United States of America
|November 13, 2004
PubMed
Summary

The LIM homeobox gene Lhx2 inhibits hepatic stellate cell activation, preventing liver fibrosis. Lhx2 deficiency in mice leads to fibrosis and disrupted liver development, establishing Lhx2 as crucial for liver health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sexual dimorphism in the association of circulating TAM receptors-ligands with MASLD-related fibrosis.

JHEP reports : innovation in hepatology·2026
Same author

Erratum to 'Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosis' [J Hepatol 83 (2025) 239-257].

Journal of hepatology·2026
Same author

Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis.

Cell·2026
Same author

Cannabinoid receptor 2 activating antibodies: A promising therapeutic strategy for macrophage-driven fibro-inflammatory diseases.

Molecular pharmacology·2026
Same author

Scar-associated endothelial-stellate cellular crosstalk drives fibrosis resolution in MASH.

Cell reports·2026
Same author

Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis.

Science translational medicine·2026

Area of Science:

  • Hepatology
  • Developmental Biology
  • Molecular Biology

Background:

  • Liver fibrosis is a pathological condition involving excessive extracellular matrix deposition, primarily driven by activated hepatic stellate cells (HSCs).
  • The LIM homeobox gene Lhx2 is known to be expressed in HSCs and plays a role in liver development.

Purpose of the Study:

  • To investigate the role of Lhx2 in regulating HSC activation and liver development.
  • To analyze the consequences of Lhx2 deficiency on liver fibrosis and cellular organization.

Main Methods:

  • Detailed analysis of liver development in Lhx2 knockout (Lhx2(-/-)) mouse embryos.
  • Assessment of HSC activation and extracellular matrix protein deposition in Lhx2(-/-) livers.
  • Gene expression analysis in HSCs and intrahepatic endodermal cells.

Related Experiment Videos

Main Results:

  • Lhx2(-/-) embryos exhibit numerous activated HSCs and increased extracellular matrix deposition, characteristic of liver fibrosis.
  • Transfection of Lhx2 cDNA into human HSCs down-regulates genes associated with HSC activation.
  • Lhx2 deficiency leads to disrupted liver cellular organization and altered gene expression in endodermal cells, with fibrosis preceding these changes.

Conclusions:

  • Lhx2 acts as a negative regulator of HSC activation, thus inhibiting liver fibrosis.
  • Inactivation of Lhx2 in developing HSCs mimics signals of chronic liver injury.
  • This study establishes a novel animal model for hepatic fibrosis and highlights Lhx2's importance in HSC function and liver development.